Invesco Hong Kong Limited reduced its shareholding of shanghai fudan-zhangjiang bio-pharmaceutical co. ltd. (01349) by 0.364 million shares at a price of approximately HK$2.17 per share.

Zhitong Finance · Sep 20 20:30

On August 5, Invesco Hong Kong Limited reduced its shareholding in Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349) by 0.364 million shares, with a price of 2.1664 Hong Kong dollars per share, for a total amount of approximately 0.7886 million Hong Kong dollars.

According to the latest information from the Hong Kong Stock Exchange, on August 5, Invesco Hong Kong Limited reduced its shareholding in Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349) by 0.364 million shares, with a price of 2.1664 Hong Kong dollars per share, for a total amount of approximately 0.7886 million Hong Kong dollars. After the reduction, the latest number of shares held is 16.16 million shares, with the latest shareholding ratio of 4.95%.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

Invesco Hong Kong Limited减持复旦张江(01349)36.4万股 每股作价约2.17港元

Invesco Hong Kong Limited reduced its shareholding of shanghai fudan-zhangjiang bio-pharmaceutical co. ltd. (01349) by 0.364 million shares at a price of approximately HK$2.17 per share.

Risk Disclaimer

Statement

Invesco Hong Kong Limited减持复旦张江(01349)36.4万股每股作价约2.17港元